AVH:ASX
AVITA Medical Inc
A$3.04
arrow_downward
-0.33%(-0.0100) 1D
Sep 21, 2:19:45 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AVH...
Open
A$3.04
High
A$3.05
Low
A$3.00
Mkt. cap
486.51M
Avg. vol.
656.08K
Volume
178.14K
52-wk high
A$3.10
52-wk low
A$1.00
Shares outstanding
30.93M
No. of employees
226
Open
A$3.04
High
A$3.05
Low
A$3.00
Mkt. cap
486.51M
Avg. vol.
656.08K
Volume
178.14K
52-wk high
A$3.10
52-wk low
A$1.00
Shares outstanding
30.93M
No. of employees
226
News stories
From web sources and news partners
careplusvn.com
·
1 month ago
Avita Medical (RCEL) Rebounds 6.26% as Biotech Stock Tests Key Resistance Zone - Overbought Signal Alerts
CarePlus VietNam
·
2 months ago
RCEL Q1 2026 Earnings: EPS Misses Estimates, Stock Gains 2.41% - EBITDA Margin Trends
Profile
Avita Medical is a clinical and commercial company developing and marketing a range of regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are PermeaDerm, a transparent, biosynthetic bilayer wound matrix used for temporary wound coverage after surgical excision of burns or trauma, and Cohealyx, a bovine-derived collagen dermal matrix used by burn and trauma surgeons to treat severe wounds and full-thickness burns by accelerating blood vessel formation in order to prepare damaged wound beds for skin autografts. Wikipedia
About AVITA Medical Inc
CEOJames Corbett
Employees226
Founded1999
HeadquartersValencia, California, United States
SectorBiotechnology
Websiteavitamedical.com